Home/ Supplements/ Black Cumin/ Nigella Sativa Capsules 200 mg

Nigella Sativa Capsules 200 mg

product on market Capsule Nootropics Depot Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Nigella Sativa Capsules 200 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
120
Servings
Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 500.0mg (76 products)

Other Ingredients

Maltodextrin Cellulose
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: As a dietary supplement, take 1 capsule daily.

Warnings & Precautions

Disclaimer: Always consult with a qualified health physician before taking any new dietary supplement.

Warning: Keep out of reach of children. Do not take this or any other supplement if under the age of 18, pregnant or nursing a baby, or if you have any known or suspected medical conditions, and/or taking prescription drug(s) or OTC medication(s).

Do not take this or any other supplement if under the age of 18, pregnant or nursing a baby, or if you have any known or suspected medical conditions, and/or taking prescription drug(s) or OTC medication(s).

Formulation Notes

Minimum Thymoquinone Content: 10%

Additional Information

Storage: Store in a cool and dry place. Keep away from direct sunlight and heat.

Metadata

Product Details

DSLD Entry Date2023-05-24
Product TypeBotanical
FormCapsule
DSLD ID285718
Data Updated2026-04-11
Research

Research Evidence

3
Research Sources
44
Avg Quality
2
Clinical Trial
1
Rct
C Effect of a Food Supplement Based on Nigella Sativa Seeds Oil and Vitamin E on Glyco-lipid Parameters in Dysglycemic and Dyslipidemic Perimenopausal Women
Clinical Trial ClinicalTrials.gov 2024
C Nigella Sativa Supplementation in Hyperlipidemia Treatment
Clinical Trial ClinicalTrials.gov 2023
C The possible short-term of Nigella sativa - L in the management of adolescent polycystic ovarian syndrome: results of a randomized controlled trial.
Rct Journal of ovarian research PubMed DOI
View all evidence for Black Cumin →
Compare

Similar Products

View all Black Cumin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.